Gadi Lachman is the Founder and Chief Executive Officer of TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies. Starting in 2014, TriNetX has grown into the largest global platform for clinical research. The network consists of hundreds of healthcare organizations (HCOs) in more than 30 countries and includes access to anonymized data of hundreds of millions of patients. Mr. Lachman has successfully led TriNetX into a mature, profitable, and fast growing organization that has disrupted the ways in which clinical research is being conducted and has improved health outcomes for patients across all therapeutic areas. TriNetX has become the number one platform for clinical research used across all large pharma companies and many smaller ones. TriNetX HCO partners include Boston Children’s Hospital, Johns Hopkins Health System, Madrid’s Hospital Universitario 12 de Octubre, and many others. Mr. Lachman has been named Entrepreneur of the Year by Ernst & Young and sits on the board of the Friends of the National Library of Medicine. Prior to founding TriNetX, Mr. Lachman held leadership positions at TriZetto, American Well, and Eliza. He also spent time at Lehman Brothers and served as an Officer in the Israeli Special Forces. Mr. Lachman earned his MBA from Harvard Business School where he was named a Baker Scholar for finishing in the top 5% of his class. He received an LL.B., Law, and B.A. in Accounting from Tel-Aviv University.